Find Mavodelpar manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

API Suppliers

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Ppar, A agonist, Ren-001 free acid, I9kp509k31, 942594-93-6, Mavodelpar
Molecular Formula
C31H30FNO5
Molecular Weight
515.6  g/mol
InChI Key
UAQOKKXVCNQHIP-IPPBACCNSA-N
FDA UNII
I9KP509K31

Mavodelpar
1 2D Structure

Mavodelpar

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2-[4-[(E)-3-(4-fluorophenyl)-3-[4-(3-morpholin-4-ylprop-1-ynyl)phenyl]prop-2-enoxy]-2-methylphenoxy]acetic acid
2.1.2 InChI
InChI=1S/C31H30FNO5/c1-23-21-28(12-13-30(23)38-22-31(34)35)37-18-14-29(26-8-10-27(32)11-9-26)25-6-4-24(5-7-25)3-2-15-33-16-19-36-20-17-33/h4-14,21H,15-20,22H2,1H3,(H,34,35)/b29-14+
2.1.3 InChI Key
UAQOKKXVCNQHIP-IPPBACCNSA-N
2.1.4 Canonical SMILES
CC1=C(C=CC(=C1)OCC=C(C2=CC=C(C=C2)C#CCN3CCOCC3)C4=CC=C(C=C4)F)OCC(=O)O
2.1.5 Isomeric SMILES
CC1=C(C=CC(=C1)OC/C=C(\C2=CC=C(C=C2)C#CCN3CCOCC3)/C4=CC=C(C=C4)F)OCC(=O)O
2.2 Other Identifiers
2.2.1 UNII
I9KP509K31
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. Ppar

2. A Agonist

3. Ren-001 Free Acid

4. I9kp509k31

5. 942594-93-6

6. Mavodelpar

7. Mavodelpar [inn]

8. Unii-i9kp509k31

9. Schembl1746564

10. Hy-112597

11. Cs-0058426

12. (4-{[(2e)-3-(4-fluorophenyl)-3-{4-[3-(morpholin-4- Yl)prop-1-yn-1-yl]phenyl}prop-2-en-1-yl]oxy}-2- Methylphenoxy)acetic Acid

13. (e)-[4-[3-(4-fluorophenyl)-3-[4-[3-(morpholin-4-yl)propynyl]phenyl]allyloxy]-2-methyl-phenoxy]acetic Acid

14. 2-[4-[[(2e)-3-(4-fluorophenyl)-3-[4-[3-(4-morpholinyl)-1-propyn-1-yl]phenyl]-2-propen-1-yl]oxy]-2-methylphenoxy]acetic Acid

15. Acetic Acid, 2-(4-(((2e)-3-(4-fluorophenyl)-3-(4-(3-(4-morpholinyl)-1-propyn-1-yl)phenyl)-2-propen-1-yl)oxy)-2-methylphenoxy)-

2.4 Create Date
2008-01-07
3 Chemical and Physical Properties
Molecular Weight 515.6 g/mol
Molecular Formula C31H30FNO5
XLogP33.5
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count7
Rotatable Bond Count10
Exact Mass g/mol
Monoisotopic Mass g/mol
Topological Polar Surface Area68.2
Heavy Atom Count38
Formal Charge0
Complexity828
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count1
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty